in male rats. Comparison of the metabolic profile of NNEI to its indazole analogue MN-18 uncovered marked distinctions in pharmacokinetic parameters and metabolic pathways. It should be mentioned that compound 183 showed crystal clear ocular hypotensive action, excellent in magnitude for The full study course from the experiment. Regardless o